Brilinta 90mg Bottle Of 180 Tablets
180 Tablet(s) in BottleMRP ₹5595.93
₹4698.26
16% OFF
Made by
ASTRAZENECA PHARMA INDIA LTD
Dosage
TABLET
Expiry
Product Summary
| Salt Content | Ticagrelor(90.0 Mg) |
| Uses | Prevent blood clot |
| Therapy | Anti-platelet |
| Side effects | Bleeding, increased uric acid, difficulty in breathing, nausea |
Assurance
available
Regulated
Medical Description
Brilinta Tablet is a prescription medication primarily used to manage and prevent cardiovascular events such as heart attacks and strokes in patients with a history of acute coronary syndrome (ACS), unstable angina, or those who have undergone stent placement. The active ingredient in Brilinta is Ticagrelor, which belongs to a class of medications known as antiplatelet agents or P2Y12 receptor inhibitors. It is often referred to as a "blood thinner," although it technically works by inhibiting platelet aggregation, rather than thinning the blood itself. Unlike traditional antiplatelet agents such as clopidogrel, Ticagrelor has a faster onset of action and does not require metabolic activation, making it more predictable in its effect. Brilinta is usually prescribed alongside low-dose aspirin and should be taken exactly as recommended by your physician.
Patients are advised not to discontinue the tablet without medical guidance, as abrupt cessation may increase the risk of serious cardiovascular events, including heart attack or stroke. The medication is not suitable for individuals with active bleeding, a history of intracranial haemorrhage, or severe liver dysfunction. It is also contraindicated in patients who are hypersensitive to Ticagrelor or any component of the formulation.
Do not miss or skip a dose of this medication. You may experience bleeding, difficulty bleeding, or headaches while on this medication. If these symptoms worsen, contact the nearest doctor or clinic. Avoid contact with sharp objects, as this can lead to excessive bleeding; for example, knives, blades, scissors, axes, etc.
Uses
- To prevent heart attacks and reduce the risk of stroke in patients who have experienced ACS or myocardial infarction (heart attack).
- To prevent blood clot formation in coronary arteries, especially in patients who have undergone stent placement, thereby reducing the risk of stent thrombosis.
- To improve outcomes in patients with a history of angina, particularly those at risk of developing more severe cardiovascular events.
- In select cases, it is used as part of dual antiplatelet therapy (DAPT) alongside aspirin for enhanced vascular protection.
Contraindications
- If you are allergic to ticagrelor or any other ingredients of Brilinta Tablet.
- If you have any active bleeding.
- If you have a history of intracranial bleeding or bleeding from ulcers in the stomach or intestine.
- If you are not being restricted to take aspirin.
- If you are already taking certain medications such as ketoconazole, clarithromycin (antibiotics), antidepressants, anti-viral medicines, etc.
Side effects
- Blood disorder bleedings
- Increased uric acid (Hyperuricemia)
- Difficulty in breathing
- Dizziness
- Headache
- Decreased blood pressure
- Diarrhoea
- Nausea
Precautions and Warnings
Pregnancy
Breast Feeding
Driving
Alcohol
Other General Warnings
- You have a bleeding disorder or any active bleeding.
- You have surgery planned.
- You have any liver or heart condition.
- You have kidney disease characterised by increased creatinine levels.
- You experience any other side effects while on this medicine.
- Your doctor may ask you to undergo a routine serum uric acid check-up.
- Sudden stoppage of this medicine can increase the risk of heart attack or stroke.
Directions for Use
Storage and disposal
Dosage
Overdose
Missed a Dose
Mode of Action
How Does It Work?
Interactions
Interactions with other medicines
- Certain medicines can interfere with the action of Brilinta Tablet if taken at the same time. Always inform your doctor about all the medicine you are taking, that includes all prescribed or non-prescribed herbal medicines, dietary supplements as well as other treatment if you are taking for any disorder.
- In particular, if you are taking medicines for tuberculosis, fits, fungal infections, anti-HIV medicine like ritonavir, antibiotics like clarithromycin, painkillers, etc.
- Other medicines that should be used with caution are anti-hypertensive medicines, medicines for heart-related diseases, immunosuppressants, etc.
Frequently Asked Questions (FAQs)
Articles
View All
Chronic Condition Articles
View All
Did you find this helpful?
Explore More at Pharmeasy
Manufacturer Details
Brand:BRILINTA
Manufacturer Name:ASTRAZENECA PHARMA INDIA LTD
Address:Astrazeneca Operations Sweden, Astrazeneca Sverige Ab, Sodertalje S-151-85, Sweden
Country of Origin:Sweden
Vendor Details
Fulfillment Information: Brilinta 90 MG Tablet (180) will be delivered by a licensed retail pharmacy nearest to your location. Order acceptance and fulfillment are dependent upon the verification of your doctor's valid prescription (where applicable) and the current stock of this medicine.
References:
- Brilique 90 mg film coated tablets - Summary of Product Characteristics (SmPC) - (emc) [Internet]. Medicines.org.uk. 2025 [cited 18 March 2025]
- Brilique 90 mg film coated tablets - Patient Information Leaflet (PIL) - (emc) [Internet]. Medicines.org.uk. 2025 [cited 18 March 2025]
- (LactMed) D. Drugs and Lactation Database (LactMed) [Internet]. Ncbi.nlm.nih.gov. 2025 [cited 18 March 2025]
- CDSCO [Internet]. Cdscoonline.gov.in. 2025 [cited 18 March 2025]
- Dobesh PP, Oestreich JH. Ticagrelor: pharmacokinetics, pharmacodynamics, clinical efficacy, and safety. Pharmacotherapy. 2014 Oct;34(10):1077-90 [cited 3 March 2025]
- Sinha N. Ticagrelor: molecular discovery to clinical evidence: ticagrelor: a novel antiplatelet agent. Indian Heart J. 2012 Sep-Oct;64(5):497-502.[cited 3 march 2025]
- DrugBank. Ticagrelor. DrugBank Online. [cited 3 March 2025]
In Case of Any Issues Contact Us
Email Id:care@pharmeasy.in
Phone Number:7666100300
Address:D-37/1, Opp. Sandoz, TTC Industrial Area, MIDC Industrial Area, Turbhe, Navi Mumbai, Maharashtra 400703
Disclaimer
The information provided herein is supplied to the best of our abilities to make it accurate and reliable as it is published after a review by a team of professionals. This information is solely intended to provide a general overview on the product and must be used for informational purposes only. You should not use the information provided herein to diagnose, prevent, or cure a health problem. Nothing contained on this page is intended to create a doctor-patient relationship, replace or be a substitute for a registered medical practitioner's medical treatment/advice or consultation. The absence of any information or warning to any medicine shall not be considered and assumed as an implied assurance. We highly recommend that you consult your registered medical practitioner for all queries or doubts related to your medical condition. You hereby agree that you shall not make any health or medical-related decision based in whole or in part on anything contained in the Site. Please click here for detailed T&C.
